To address whether SRC-3 inhibition changes the cytokine profile in breast tumors, E0771 tumors were harvested from tumor-bearing C57BL/6J mice on the 23rd day after SI-2 or vehicle treatment (Fig. 10A). This evidence concerns the gene NCOA3 and neoplasm.